This talk will cover recent clinical trials presented at the ADA in 2021 that have an impact on the management of diabetes. The faculty will take you through the latest guidelines from the ADA regarding the management of type 2 diabetes and describe how recent clinical trial data has been integrated in to these guidelines. 

Martin J. Abrahamson, MD, FACP

Associate Professor of Medicine, Harvard Medical School, Director, Division of CME, Beth Israel Deaconess Medical Center, Boston, MA

Personality disorders are a class of mental disorders characterized by pervasive maladaptive patterns of behavior, cognition, and inner experience, exhibited across many contexts and deviating from cultural norms. These patterns are inflexible and are associated with distress and impairment. That said, the definitions are controversial. Case examples will illustrate this class of mental disorders, along with suggested non-pharmacological and pharmacological interventions. 

Shirah Vollmer, MD

Clinical Professor of Psychiatry, David Geffen School of Medicine at UCLA, Los Angeles, CA

This activity will provide an evidence-based approach to the diagnosis and management of irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.

Philip Schoenfeld, MD, MSEd, MSc

Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI

Supported by Allergan and Ironwood Pharmaceuticals, Inc. Salix Pharmaceuticals

Vaccination is a cornerstone of preventive medicine. However, many individuals fail to receive the benefits of vaccination due to growing vaccine hesitancy and a lack of effective communication about vaccines. This is especially troubling amidst the COVID-19 pandemic, as decisions to decline COVID-19 vaccination present not only increased risk to individuals but also an immediate and massive public health risk. This public health problem is magnified in already health-disparate communities, such as those of Black and Hispanic individuals, in the United States. In this session, Dr. Robert Hopkins and Dr. Gregory Hall will address these concerns by raising PCPs’ awareness of vaccine hesitancy and their understanding of how it affects diverse populations differently. The education will provide PCPs with concrete strategies, including culturally competent communication, to overcome vaccine hesitancy in patients from all backgrounds. 

Robert H. Hopkins Jr., MD, FACP, FAAP

Professor of Internal Medicine and Pediatrics, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AR

Gregory L. Hall, MD

Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, Director, Center for African American Health, Research, Education & Policy, Cleveland, OH

Supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP

Despite the array of products and minimal regulation, it is possible to find high quality dietary supplements and use them in a rational evidence-informed manner in the care of many primary care problems. Discussion goes beyond the management of so-called short latency deficiency syndromes taught in the past to current applications for a few common primary care problems such as anxiety, depression, emotional and physical exhaustion and insomnia. We will also identify those who may need adjuncts to their diet and useful databases to find more information.

Donald B. Levy, MD

Medical Director, Osher Clinical Center for Integrative Medicine, Brigham and Women’s Hospital, Assistant Professor of Medicine, Harvard Medical School, Boston, MA

Primary care patients who present with cognitive change represent a clinical challenge. Delirium must be differentiated from dementia, as delirium represents a medical emergency. In this session, potential causes of delirium, Alzheimer disease and other leading causes of dementia will be reviewed. Faculty will outline the clinical findings, screening tools, diagnostic studies, and potential therapies for cognitive decline in the geriatric patient.  

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chairperson, Philadelphia College of Osteopathic Medicine, Philadelphia, PA